{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T16:16:56Z","timestamp":1742919416071,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":74,"publisher":"Springer New York","isbn-type":[{"type":"print","value":"9781493995929"},{"type":"electronic","value":"9781493995936"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-1-4939-9593-6_1","type":"book-chapter","created":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T18:11:38Z","timestamp":1561486298000},"page":"1-27","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Working Safely with Vaccinia Virus: Laboratory Technique and Review of Published Cases of Accidental Laboratory Infections with Poxviruses"],"prefix":"10.1007","author":[{"given":"Stuart N.","family":"Isaacs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,26]]},"reference":[{"key":"1_CR1","first-page":"2129","volume-title":"Fields virology","author":"B Moss","year":"2013","unstructured":"Moss B (2013) Poxviridae: the viruses and their replication. In: Knipe DM, Howley PM, Cohen JI et al (eds) Fields virology, 6th edn. Wolters Kluwer\/Lippincott Williams & Wilkins Health, Philadelphia, PA, pp 2129\u20132159","edition":"6"},{"key":"1_CR2","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1146\/annurev.immunol.21.120601.141049","volume":"21","author":"BT Seet","year":"2003","unstructured":"Seet BT, Johnston JB, Brunetti CR, Barrett JW, Everett H, Cameron C, Sypula J, Nazarian SH, Lucas A, McFadden G (2003) Poxviruses and immune evasion. Annu Rev Immunol 21:377\u2013423","journal-title":"Annu Rev Immunol"},{"issue":"Suppl","key":"1_CR3","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1017\/S0031182005008127","volume":"130","author":"IR Haga","year":"2005","unstructured":"Haga IR, Bowie AG (2005) Evasion of innate immunity by vaccinia virus. Parasitology 130(Suppl):S11\u2013S25","journal-title":"Parasitology"},{"issue":"21","key":"1_CR4","doi-asserted-by":"publisher","first-page":"11341","DOI":"10.1073\/pnas.93.21.11341","volume":"93","author":"B Moss","year":"1996","unstructured":"Moss B (1996) Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety. Proc Natl Acad Sci U S A 93(21):11341\u201311348","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"1_CR5","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0958-1669(97)80031-6","volume":"8","author":"MW Carroll","year":"1997","unstructured":"Carroll MW, Moss B (1997) Poxviruses as expression vectors. Curr Opin Biotechnol 8(5):573\u2013577","journal-title":"Curr Opin Biotechnol"},{"issue":"4383","key":"1_CR6","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1126\/science.419409","volume":"203","author":"N Hawkes","year":"1979","unstructured":"Hawkes N (1979) Smallpox death in Britain challenges presumption of laboratory safety. Science 203(4383):855\u2013856","journal-title":"Science"},{"key":"1_CR7","first-page":"341","volume":"34","author":"CDC","year":"1985","unstructured":"CDC (1985) Recommendations of the immunization practices advisory committee smallpox vaccine. MMWR Morb Mortal Wkly Rep 34:341\u2013342","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"RR-14","key":"1_CR8","first-page":"1","volume":"40","author":"CDC","year":"1991","unstructured":"CDC (1991) Vaccinia (smallpox) vaccine. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep 40(RR-14):1\u201310","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"RR10","key":"1_CR9","first-page":"1","volume":"50","author":"CDC","year":"2001","unstructured":"CDC (2001) Vaccinia (smallpox) vaccine Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. MMWR Morb Mortal Wkly Rep 50(RR10):1\u201325","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"RR-7","key":"1_CR10","first-page":"1","volume":"52","author":"CDC","year":"2003","unstructured":"CDC (2003) Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 52(RR-7):1\u201316","journal-title":"MMWR Recomm Rep"},{"issue":"13","key":"1_CR11","first-page":"282","volume":"52","author":"CDC","year":"2003","unstructured":"CDC (2003) Supplemental recommendations on adverse events following smallpox vaccine in the pre-event vaccination program: recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 52(13):282\u2013284","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"1_CR12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.15585\/mmwr.mm6510a2","volume":"65","author":"BW Petersen","year":"2016","unstructured":"Petersen BW, Harms TJ, Reynolds MG, Harrison LH (2016) Use of vaccinia virus smallpox vaccine in laboratory and health care personnel at risk for occupational exposure to orthopoxviruses\u2014recommendations of the Advisory Committee on Immunization Practices (ACIP), 2015. MMWR Morb Mortal Wkly Rep 65(10):257\u2013262. https:\/\/doi.org\/10.15585\/mmwr.mm6510a2","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1_CR13","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/319543a0","volume":"319","author":"L Jones","year":"1986","unstructured":"Jones L, Ristow S, Yilma T, Moss B (1986) Accidental human vaccination with vaccinia virus expressing nucleoprotein gene. Nature 319:543","journal-title":"Nature"},{"key":"1_CR14","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/0140-6736(91)91093-A","volume":"338","author":"PJ Openshaw","year":"1991","unstructured":"Openshaw PJ, Alwan WH, Cherrie AH, Record FM (1991) Accidental infection of laboratory worker with recombinant vaccinia virus. Lancet 338:459","journal-title":"Lancet"},{"issue":"8","key":"1_CR15","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1056\/NEJMoa010560","volume":"345","author":"CE Rupprecht","year":"2001","unstructured":"Rupprecht CE, Blass L, Smith K, Orciari LA, Niezgoda M, Whitfield SG, Gibbons RV, Guerra M, Hanlon CA (2001) Human infection due to recombinant vaccinia-rabies glycoprotein virus. N Engl J Med 345(8):582\u2013586","journal-title":"N Engl J Med"},{"issue":"6","key":"1_CR16","first-page":"724","volume":"9","author":"N Moussatche","year":"2003","unstructured":"Moussatche N, Tuyama M, Kato SE, Castro AP, Njaine B, Peralta RH, Peralta JM, Damaso CR, Barroso PF (2003) Accidental infection of laboratory worker with vaccinia virus. Emerg Infect Dis 9(6):724\u2013726","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"1_CR17","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1046\/j.1523-1747.2003.12074.x","volume":"120","author":"M Mempel","year":"2003","unstructured":"Mempel M, Isa G, Klugbauer N, Meyer H, Wildi G, Ring J, Hofmann F, Hofmann H (2003) Laboratory acquired infection with recombinant vaccinia virus containing an immunomodulating construct. J Invest Dermatol 120(3):356\u2013358","journal-title":"J Invest Dermatol"},{"issue":"15","key":"1_CR18","first-page":"134","volume":"29","author":"M Loeb","year":"2003","unstructured":"Loeb M, Zando I, Orvidas MC, Bialachowski A, Groves D, Mahoney J (2003) Laboratory-acquired vaccinia infection. Can Commun Dis Rep 29(15):134\u2013136","journal-title":"Can Commun Dis Rep"},{"issue":"3","key":"1_CR19","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1386-6532(03)00118-5","volume":"29","author":"CG Wlodaver","year":"2004","unstructured":"Wlodaver CG, Palumbo GJ, Waner JL (2004) Laboratory-acquired vaccinia infection. J Clin Virol 29(3):167\u2013170","journal-title":"J Clin Virol"},{"issue":"1","key":"1_CR20","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3201\/eid1201.051126","volume":"12","author":"FM Lewis","year":"2006","unstructured":"Lewis FM, Chernak E, Goldman E, Li Y, Karem K, Damon IK, Henkel R, Newbern EC, Ross P, Johnson CC (2006) Ocular vaccinia infection in laboratory worker, Philadelphia, 2004. Emerg Infect Dis 12(1):134\u2013137","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"1_CR21","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.7205\/MILMED.172.10.1117","volume":"172","author":"WF Peate","year":"2007","unstructured":"Peate WF (2007) Prevention of vaccinia infection in a laboratory worker. Mil Med 172(10):1117\u20131118","journal-title":"Mil Med"},{"issue":"11","key":"1_CR22","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/j.1365-2893.2007.00872.x","volume":"14","author":"C Eisenbach","year":"2007","unstructured":"Eisenbach C, Neumann-Haefelin C, Freyse A, Korsukewitz T, Hoyler B, Stremmel W, Thimme R, Encke J (2007) Immune responses against HCV-NS3 after accidental infection with HCV-NS3 recombinant vaccinia virus. J Viral Hepat 14(11):817\u2013819","journal-title":"J Viral Hepat"},{"issue":"15","key":"1_CR23","first-page":"401","volume":"57","author":"CDC","year":"2008","unstructured":"CDC (2008) Laboratory-acquired vaccinia exposures and infections\u2014United States, 2005\u20132007. MMWR Morb Mortal Wkly Rep 57(15):401\u2013404","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"29","key":"1_CR24","first-page":"797","volume":"58","author":"CDC","year":"2009","unstructured":"CDC (2009) Laboratory-acquired vaccinia virus infection\u2014Virginia, 2008. MMWR Morb Mortal Wkly Rep 58(29):797\u2013800","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"11-12","key":"1_CR25","doi-asserted-by":"crossref","first-page":"657","DOI":"10.5694\/j.1326-5377.2009.tb03368.x","volume":"191","author":"SN Senanayake","year":"2009","unstructured":"Senanayake SN (2009) Needlestick injury with smallpox vaccine. Med J Aust 191(11-12):657","journal-title":"Med J Aust"},{"issue":"43","key":"1_CR26","first-page":"1204","volume":"58","author":"CDC","year":"2009","unstructured":"CDC (2009) Human vaccinia infection after contact with a raccoon rabies vaccine bait\u2014Pennsylvania, 2009. MMWR Morb Mortal Wkly Rep 58(43):1204\u20131207","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"1_CR27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/infdis\/jis302","volume":"206","author":"AM McCollum","year":"2012","unstructured":"McCollum AM, Austin C, Nawrocki J, Howland J, Pryde J, Vaid A, Holmes D, Weil MR, Li Y, Wilkins K, Zhao H, Smith SK, Karem K, Reynolds MG, Damon IK (2012) Investigation of the first laboratory-acquired human cowpox virus infection in the United States. J Infect Dis 206(1):63\u201368. https:\/\/doi.org\/10.1093\/infdis\/jis302","journal-title":"J Infect Dis"},{"issue":"2","key":"1_CR28","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3201\/eid2002.130358","volume":"20","author":"T Riyesh","year":"2014","unstructured":"Riyesh T, Karuppusamy S, Bera BC, Barua S, Virmani N, Yadav S, Vaid RK, Anand T, Bansal M, Malik P, Pahuja I, Singh RK (2014) Laboratory-acquired buffalopox virus infection, India. Emerg Infect Dis 20(2):324\u2013326. https:\/\/doi.org\/10.3201\/eid2002.130358","journal-title":"Emerg Infect Dis"},{"issue":"16","key":"1_CR29","first-page":"435","volume":"64","author":"CH Hsu","year":"2015","unstructured":"Hsu CH, Farland J, Winters T, Gunn J, Caron D, Evans J, Osadebe L, Bethune L, McCollum AM, Patel N, Wilkins K, Davidson W, Petersen B, Barry MA, Centers for Disease Control and Prevention (2015) Laboratory-acquired vaccinia virus infection in a recently immunized person\u2014Massachusetts, 2013. MMWR Morb Mortal Wkly Rep 64(16):435\u2013438","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1_CR30","unstructured":"Office of Recombinant DNA Activities; recombinant DNA research: action under the guidelines. National Institutes of Health (NIH), PHS, DHHS (2016) Notice of action under the NIH Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines). Fed Regist 81 ( https:\/\/osp.od.nih.gov\/wp-content\/uploads\/NIH_Guidelines.html )"},{"issue":"1","key":"1_CR73","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1615\/CritRevImmunol.v22.i1.20","volume":"22","author":"JY Niederkorn","year":"2002","unstructured":"Niederkorn JY (2002) Immune privilege in the anterior chamber of the eye. Crit Rev Immunol 22(1):13\u201346","journal-title":"Crit Rev Immunol"},{"key":"1_CR74","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1001\/archopht.1970.00990040047012","volume":"84","author":"FL Ruben","year":"1970","unstructured":"Ruben FL, Lane JM (1970) Ocular vaccinia. An epidemiologic analysis of 348 cases. Arch Ophthalmol 84:45\u201348","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"1_CR31","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0166-3542(00)00067-X","volume":"45","author":"EA Jonczy","year":"2000","unstructured":"Jonczy EA, Daly J, Kotwal GJ (2000) A novel approach using an attenuated recombinant vaccinia virus to test the antipoxviral effects of hand soaps. Antiviral Res 45(2):149\u2013153","journal-title":"Antiviral Res"},{"key":"1_CR32","volume-title":"Biosafety in microbiological and biomedical laboratories. HHS publication; no. (CDC) 93-8395","year":"1999","unstructured":"Richmond JY, RW MK (eds) (1999) Biosafety in microbiological and biomedical laboratories. HHS publication; no. (CDC) 93-8395, 4th edn. U.S. Department of Health and Human Services, PHS, CDC, NIH, Washington DC","edition":"4"},{"key":"1_CR33","volume-title":"Disinfection, sterilization, and preservation","year":"2001","unstructured":"Block SS (ed) (2001) Disinfection, sterilization, and preservation, 5th edn. Lippincott Williams & Wilkins, Philadelphia","edition":"5"},{"issue":"7","key":"1_CR34","doi-asserted-by":"publisher","first-page":"624","DOI":"10.4065\/77.7.624","volume":"77","author":"MJ Espy","year":"2002","unstructured":"Espy MJ, Uhl JR, Sloan LM, Rosenblatt JE, Cockerill FR 3rd, Smith TF (2002) Detection of vaccinia virus, herpes simplex virus, varicella-zoster virus, and Bacillus anthracis DNA by LightCycler polymerase chain reaction after autoclaving: implications for biosafety of bioterrorism agents. Mayo Clin Proc 77(7):624\u2013628","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"1_CR35","first-page":"207","volume":"57","author":"CDC","year":"2008","unstructured":"CDC (2008) Notice to readers: newly licensed smallpox vaccine to replace old smallpox vaccine. MMWR Morb Mortal Wkly Rep 57(8):207\u2013208","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1_CR36","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0140-6736(89)91578-X","volume":"2","author":"D Baxby","year":"1989","unstructured":"Baxby D (1989) Smallpox vaccination for investigators. Lancet 2:919","journal-title":"Lancet"},{"issue":"8663","key":"1_CR37","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/S0140-6736(89)90760-5","volume":"2","author":"RP Wenzel","year":"1989","unstructured":"Wenzel RP, Nettleman MD (1989) Smallpox vaccination for investigators using vaccinia recombinants. Lancet 2(8663):630\u2013631","journal-title":"Lancet"},{"key":"1_CR38","first-page":"757","volume":"34","author":"GF Perry","year":"1992","unstructured":"Perry GF (1992) Occupational medicine forum. J Occup Med 34:757","journal-title":"J Occup Med"},{"issue":"4","key":"1_CR39","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/0264-410X(93)90277-5","volume":"11","author":"D Baxby","year":"1993","unstructured":"Baxby D (1993) Indications for smallpox vaccination: policies still differ. Vaccine 11(4):395\u2013396","journal-title":"Vaccine"},{"key":"1_CR40","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/occmed\/43.3.125","volume":"43","author":"NR Williams","year":"1993","unstructured":"Williams NR, Cooper BM (1993) Counselling of workers handling vaccinia virus. Occup Med (Oxf) 43:125\u2013127","journal-title":"Occup Med (Oxf)"},{"issue":"9","key":"1_CR41","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1136\/oem.59.9.573","volume":"59","author":"SN Isaacs","year":"2002","unstructured":"Isaacs SN (2002) Critical evaluation of smallpox vaccination for laboratory workers. Occup Environ Med 59(9):573\u2013574","journal-title":"Occup Environ Med"},{"key":"1_CR42","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1056\/NEJM196911272812201","volume":"281","author":"JM Lane","year":"1969","unstructured":"Lane JM, Ruben FL, Neff JM, Millar JD (1969) Complications of smallpox vaccination, 1968. National surveillance in the United States. New Engl J Med 281:1201\u20131208","journal-title":"New Engl J Med"},{"key":"1_CR43","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/infdis\/122.4.303","volume":"122","author":"JM Lane","year":"1970","unstructured":"Lane JM, Ruben FL, Neff JM, Millar JD (1970) Complications of smallpox vaccination, 1968: results of ten statewide surveys. J Infect Dis 122:303\u2013309","journal-title":"J Infect Dis"},{"issue":"17\u201318","key":"1_CR44","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1016\/j.vaccine.2005.01.012","volume":"23","author":"GA Poland","year":"2005","unstructured":"Poland GA, Grabenstein JD, Neff JM (2005) The US smallpox vaccination program: a review of a large modern era smallpox vaccination implementation program. Vaccine 23(17\u201318):2078\u20132081","journal-title":"Vaccine"},{"issue":"8","key":"1_CR45","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1086\/428731","volume":"40","author":"J Baggs","year":"2005","unstructured":"Baggs J, Chen RT, Damon IK, Rotz L, Allen C, Fullerton KE, Casey C, Nordenberg D, Mootrey G (2005) Safety profile of smallpox vaccine: insights from the laboratory worker smallpox vaccination program. Clin Infect Dis 40(8):1133\u20131140","journal-title":"Clin Infect Dis"},{"issue":"5","key":"1_CR46","first-page":"103","volume":"53","author":"CDC","year":"2004","unstructured":"CDC (2004) Secondary and tertiary transfer of vaccinia virus among U.S. military personnel\u2014United States and worldwide, 2002\u20132004. MMWR Morb Mortal Wkly Rep 53(5):103\u2013105","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"19","key":"1_CR47","first-page":"478","volume":"56","author":"CDC","year":"2007","unstructured":"CDC (2007) Household transmission of vaccinia virus from contact with a military smallpox vaccinee\u2013Illinois and Indiana, 2007. MMWR Morb Mortal Wkly Rep 56(19):478\u2013481","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"17","key":"1_CR48","first-page":"417","volume":"56","author":"CDC","year":"2007","unstructured":"CDC (2007) Vulvar vaccinia infection after sexual contact with a military smallpox vaccinee\u2013Alaska, 2006. MMWR Morb Mortal Wkly Rep 56(17):417\u2013419","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"25","key":"1_CR49","first-page":"773","volume":"59","author":"CDC","year":"2010","unstructured":"CDC (2010) Vaccinia virus infection after sexual contact with a military smallpox vaccinee\u2013Washington, 2010. MMWR Morb Mortal Wkly Rep 59(25):773\u2013775","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"1_CR50","doi-asserted-by":"publisher","first-page":"718","DOI":"10.3201\/eid1704.101316","volume":"17","author":"GE Young","year":"2011","unstructured":"Young GE, Hidalgo CM, Sullivan-Frohm A, Schult C, Davis S, Kelly-Cirino C, Egan C, Wilkins K, Emerson GL, Noyes K, Blog D (2011) Secondary and tertiary transmission of vaccinia virus from US military service member. Emerg Infect Dis 17(4):718\u2013721","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"1_CR51","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3201\/eid1704.101010","volume":"17","author":"CM Hughes","year":"2011","unstructured":"Hughes CM, Blythe D, Li Y, Reddy R, Jordan C, Edwards C, Adams C, Conners H, Rasa C, Wilby S, Russell J, Russo KS, Somsel P, Wiedbrauk DL, Dougherty C, Allen C, Frace M, Emerson G, Olson VA, Smith SK, Braden Z, Abel J, Davidson W, Reynolds M, Damon IK (2011) Vaccinia virus infections in martial arts gym, Maryland, USA, 2008. Emerg Infect Dis 17(4):730\u2013733","journal-title":"Emerg Infect Dis"},{"key":"1_CR52","unstructured":"Advisory Committee on Dangerous Pathogens and Advisory Committee on Genetic Modifications (1990; re-issued 2011) Vaccination of laboratory workers handling vaccinia and related poxviruses infectious for humans. HMSO Publications Center, London ( http:\/\/www.hse.gov.uk\/pUbns\/priced\/acdp-acgm-vaccine.pdf )"},{"issue":"3","key":"1_CR53","doi-asserted-by":"publisher","first-page":"viii","DOI":"10.1046\/j.1523-1747.2003.12072.x","volume":"120","author":"VA Fulginiti","year":"2003","unstructured":"Fulginiti VA (2003) The risks of vaccinia in laboratory workers. J Invest Dermatol 120(3):viii","journal-title":"J Invest Dermatol"},{"issue":"1","key":"1_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virol.2008.11.045","volume":"385","author":"A MacNeil","year":"2009","unstructured":"MacNeil A, Reynolds MG, Damon IK (2009) Risks associated with vaccinia virus in the laboratory. Virology 385(1):1\u20134","journal-title":"Virology"},{"issue":"4","key":"1_CR55","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1517\/13543784.17.4.555","volume":"17","author":"RN Greenberg","year":"2008","unstructured":"Greenberg RN, Kennedy JS (2008) ACAM2000: a newly licensed cell culture-based live vaccinia smallpox vaccine. Expert Opin Investig Drugs 17(4):555\u2013564","journal-title":"Expert Opin Investig Drugs"},{"issue":"1","key":"1_CR56","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1586\/14760584.8.1.13","volume":"8","author":"JS Kennedy","year":"2009","unstructured":"Kennedy JS, Greenberg RN (2009) IMVAMUNE: modified vaccinia Ankara strain as an attenuated smallpox vaccine. Expert Rev Vaccines 8(1):13\u201324","journal-title":"Expert Rev Vaccines"},{"issue":"5","key":"1_CR57","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1128\/AAC.01596-08","volume":"53","author":"R Jordan","year":"2009","unstructured":"Jordan R, Goff A, Frimm A, Corrado ML, Hensley LE, Byrd CM, Mucker E, Shamblin J, Bolken TC, Wlazlowski C, Johnson W, Chapman J, Twenhafel N, Tyavanagimatt S, Amantana A, Chinsangaram J, Hruby DE, Huggins J (2009) ST-246 antiviral efficacy in a nonhuman primate monkeypox model: determination of the minimal effective dose and human dose justification. Antimicrob Agents Chemother 53(5):1817\u20131822","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"1_CR58","doi-asserted-by":"publisher","first-page":"4900","DOI":"10.1128\/AAC.00904-12","volume":"56","author":"J Chinsangaram","year":"2012","unstructured":"Chinsangaram J, Honeychurch KM, Tyavanagimatt SR, Leeds JM, Bolken TC, Jones KF, Jordan R, Marbury T, Ruckle J, Mee-Lee D, Ross E, Lichtenstein I, Pickens M, Corrado M, Clarke JM, Frimm AM, Hruby DE (2012) Safety and pharmacokinetics of the anti-orthopoxvirus compound ST-246 following a single daily oral dose for 14 days in human volunteers. Antimicrob Agents Chemother 56(9):4900\u20134905. https:\/\/doi.org\/10.1128\/AAC.00904-12","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"1_CR59","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.3390\/v2122740","volume":"1","author":"R Lanier","year":"2010","unstructured":"Lanier R, Trost L, Tippin T, Lampert B, Robertson A, Foster S, Rose M, Painter W, O\u2019Mahony R, Almond M, Painter G (2010) Development of CMX001 for the treatment of poxvirus infections. Viruses 1(12):2740\u20132762","journal-title":"Viruses"},{"issue":"1","key":"1_CR60","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/occmed\/kqp120","volume":"60","author":"N Benzekri","year":"2010","unstructured":"Benzekri N, Goldman E, Lewis F, Johnson CC, Reynolds SM, Reynolds MG, Damon IK (2010) Laboratory worker knowledge, attitudes and practices towards smallpox vaccine. Occup Med (Lond) 60(1):75\u201377","journal-title":"Occup Med (Lond)"},{"key":"1_CR61","series-title":"Methods in Molecular Biology","doi-asserted-by":"publisher","DOI":"10.1385\/1592597890","volume-title":"Vaccinia virus and poxvirology: Methods and protocols","author":"SN Isaacs","year":"2004","unstructured":"Isaacs SN (2004) Vaccinia virus and poxvirology: Methods and protocols, Methods in Molecular Biology. Humana Press, c2004, Totowa, NJ"},{"key":"1_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-61779-876-4_1","volume":"890","author":"SN Isaacs","year":"2012","unstructured":"Isaacs SN (2012) Working safely with vaccinia virus: laboratory technique and review of published cases of accidental laboratory infections. Methods Mol Biol 890:1\u201322. https:\/\/doi.org\/10.1007\/978-1-61779-876-4_1","journal-title":"Methods Mol Biol"},{"issue":"19","key":"1_CR63","first-page":"532","volume":"58","author":"CDC","year":"2009","unstructured":"CDC (2009) Progressive vaccinia in a military smallpox vaccinee\u2014United States, 2009. MMWR Morb Mortal Wkly Rep 58(19):532\u2013536","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"1_CR64","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1086\/587668","volume":"46","author":"S Vora","year":"2008","unstructured":"Vora S, Damon I, Fulginiti V, Weber SG, Kahana M, Stein SL, Gerber SI, Garcia-Houchins S, Lederman E, Hruby D, Collins L, Scott D, Thompson K, Barson JV, Regnery R, Hughes C, Daum RS, Li Y, Zhao H, Smith S, Braden Z, Karem K, Olson V, Davidson W, Trindade G, Bolken T, Jordan R, Tien D, Marcinak J (2008) Severe eczema vaccinatum in a household contact of a smallpox vaccinee. Clin Infect Dis 46(10):1555\u20131561. https:\/\/doi.org\/10.1086\/587668","journal-title":"Clin Infect Dis"},{"issue":"RR-4","key":"1_CR65","first-page":"1","volume":"52","author":"J Cono","year":"2003","unstructured":"Cono J, Casey CG, Bell DM (2003) Smallpox vaccination and adverse reactions. Guidance for clinicians. MMWR Recomm Rep 52(RR-4):1\u201328","journal-title":"MMWR Recomm Rep"},{"issue":"21","key":"1_CR66","first-page":"492","volume":"52","author":"CDC","year":"2003","unstructured":"CDC (2003) Update: cardiac-related events during the civilian smallpox vaccination program\u2014United States, 2003. MMWR Morb Mortal Wkly Rep 52(21):492\u2013496","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"24","key":"1_CR67","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.1001\/jama.289.24.3283","volume":"289","author":"JS Halsell","year":"2003","unstructured":"Halsell JS, Riddle JR, Atwood JE, Gardner P, Shope R, Poland GA, Gray GC, Ostroff S, Eckart RE, Hospenthal DR, Gibson RL, Grabenstein JD, Arness MK, Tornberg DN (2003) Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel. JAMA 289(24):3283\u20133289","journal-title":"JAMA"},{"key":"1_CR68","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1128\/BR.23.2.61-95.1959","volume":"23","author":"BA Briody","year":"1959","unstructured":"Briody BA (1959) Response of mice to ectromelia and vaccinia viruses. Bacteriol Rev 23:61\u201395","journal-title":"Bacteriol Rev"},{"key":"1_CR69","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1128\/JVI.66.5.2617-2630.1992","volume":"66","author":"SL Lee","year":"1992","unstructured":"Lee SL, Roos JM, McGuigan LC, Smith KA, Cormier N, Cohen LK, Roberts BE, Payne LG (1992) Molecular attenuation of vaccinia virus: mutant generation and animal characterization. J Virol 66:2617\u20132630","journal-title":"J Virol"},{"issue":"1","key":"1_CR70","first-page":"85","volume":"53","author":"DJ Gaertner","year":"2003","unstructured":"Gaertner DJ, Batchelder M, Herbst LH, Kaufman HL (2003) Administration of vaccinia virus to mice may cause contact or bedding sentinel mice to test positive for orthopoxvirus antibodies: case report and follow-up investigation. Comp Med 53(1):85\u201388","journal-title":"Comp Med"},{"issue":"2","key":"1_CR71","first-page":"57","volume":"41","author":"RK Holt","year":"2002","unstructured":"Holt RK, Walker BK, Ruff AJ (2002) Horizontal transmission of recombinant vaccinia virus in strain 13 guinea pigs. Contemp Top Lab Anim Sci 41(2):57\u201360","journal-title":"Contemp Top Lab Anim Sci"},{"issue":"3","key":"1_CR72","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1067\/mai.2002.128052","volume":"110","author":"RJ Engler","year":"2002","unstructured":"Engler RJ, Kenner J, Leung DY (2002) Smallpox vaccination: risk considerations for patients with atopic dermatitis. J Allergy Clin Immunol 110(3):357\u2013365","journal-title":"J Allergy Clin Immunol"}],"container-title":["Methods in Molecular Biology","Vaccinia Virus"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-9593-6_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T21:57:44Z","timestamp":1610056664000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-9593-6_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9781493995929","9781493995936"],"references-count":74,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-9593-6_1","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"26 June 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}